2013 Annual Meeting | Amyloid Imaging: Are Neurologists Ready for the Paradigm Shift?

Date Monday 03/18/13

Time 02:00 PM - 06:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Half-Day Course

Director(s) Norman L. Foster, MD, FAAN

Topic(s)

Learning Objectives Participants should understand when amyloid PET imaging is appropriate and inappropriate, be able to identify when amyloid PET results are reliable and when they may be misleading, be able to incorporate amyloid PET scan results to increase diagnostic confidence and accuracy of cognitive evaluations, and consider ethical issues when talking to patients about amyloid PET imaging.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Program Tracks Subspecialty in Focus

Recommended Audience Other, Trainee, General Neurologist, Specialist Neurologist, Non-neurologist

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
02:00 PM - 02:15 PM		Introduction Norman L. Foster, MD, FAAN
02:15 PM - 03:15 PM		Appropriate and Inappropriate Use Recommendations for Clinical Amyloid PET Keith A. Johnson, MD
03:15 PM - 04:15 PM		Technical Issues, Communicating with Nuclear Medicine Physicians, and Reimbursement John M. Hoffman, MD
04:15 PM - 04:30 PM		Break
04:30 PM - 05:00 PM		Ethical Considerations in Using Amyloid Imaging Jason H. Karlawish, MD
05:00 PM - 06:00 PM		Discussion of Cases with Audience and Faculty: To Scan or Not to Scan Norman L. Foster, MD, FAAN

Faculty Disclosures
Norman L. Foster, MD, FAAN	No disclosure on file
Keith A. Johnson, MD	Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. An immediate family member of Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. An immediate family member of Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. An immediate family member of Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena. An immediate family member of Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NervGen. An immediate family member of Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oligomerix. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AC Immune. The institution of Dr. Johnson has received research support from National Institute on Aging. The institution of an immediate family member of Dr. Johnson has received research support from Alzheimer's Association. The institution of an immediate family member of Dr. Johnson has received research support from Eli Lilly and Co. The institution of Dr. Johnson has received research support from Eisai. The institution of an immediate family member of Dr. Johnson has received research support from Eisai.
Jason H. Karlawish, MD	No disclosure on file
John M. Hoffman, MD	No disclosure on file